Skip to main content
Clinical Trials/NCT04757519
NCT04757519
Active, not recruiting
Not Applicable

Enhancing the Diabetes Prevention Program to Promote Weight Loss Among Nonresponders in a Community-Based Lifestyle Intervention.

Lovoria Williams21 sites in 1 country403 target enrollmentFebruary 18, 2021

Overview

Phase
Not Applicable
Intervention
DPP-GLB Standard
Conditions
Diabetes
Sponsor
Lovoria Williams
Enrollment
403
Locations
21
Primary Endpoint
Change in Weight at 6 Months
Status
Active, not recruiting
Last Updated
3 months ago

Overview

Brief Summary

This study seeks to establish the efficacy of identifying weight loss nonresponders early in a Diabetes Prevention Program (DPP) intervention in 20 community settings (primarily churches and community centers) and providing them with individual-level, enhanced treatment through telephone contacts and access to additional resources. Additionally, potential mediators and moderators of the relationship between intervention status and weight loss response at 6 months in both nonresponders and responders will be examined and a cost-effectiveness analysis to evaluate the cost of the intervention will be conducted.

This study addresses key gaps in the literature about the weight loss effects of identifying nonresponders early and characterizing individuals who need more intense personalized strategies. The investigators hypothesize that changes between baseline and 3 months will be more pronounced among the nonresponders in the intervention group compared to the nonresponders in the active control group.

Registry
clinicaltrials.gov
Start Date
February 18, 2021
End Date
June 30, 2026
Last Updated
3 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Lovoria Williams
Responsible Party
Sponsor Investigator
Principal Investigator

Lovoria Williams

Associate Professor

University of Kentucky

Eligibility Criteria

Inclusion Criteria

  • self-described as Black
  • non-diabetic
  • body mass index (BMI) equal to or greater than 25
  • CDC diabetes risk assessment greater than or equal to 5 or diabetes pre-diagnosis or history of gestational diabetes
  • live within driving distance of participating church/site

Exclusion Criteria

  • diagnosed Type 1 or 2 diabetes
  • pregnant or planning to become pregnant during study period
  • contraindications to moderate physical activity
  • serious medical condition that contradicts weight loss
  • not Black or African American

Arms & Interventions

DPP-GLB Standard

Participants in this group will receive the standard Diabetes Prevention Program Group Lifestyle Balance (DPP-GLP) Intervention Program.

Intervention: DPP-GLB Standard

DPP-GLB Enhanced

Participants in this group will receive the enhanced Diabetes Prevention Program Group Lifestyle Balance (DPP-GLP) Intervention Program.

Intervention: DPP-GLB Enhanced

Outcomes

Primary Outcomes

Change in Weight at 6 Months

Time Frame: 6 months (at baseline and 6 months)

Weight will be measured in pounds using a cellular scale at baseline and at 6 months.

Change in Weight at 12 Weeks

Time Frame: 12 weeks (at baseline and12 weeks)

Weight will be measured in pounds using a cellular scale at baseline and at 12 weeks.

Secondary Outcomes

  • Change in Blood Pressure at 6 Months(6 months (at baseline and 6 months))
  • Change in Blood Pressure at 12 Weeks(12 weeks (at baseline and 12 weeks))
  • Impact of Weight on Quality of Life(6 months)
  • Change in Physical Activity at 12 Weeks(12 weeks (at baseline and 12 weeks))
  • Change in Physical Activity at 6 Months(6 months (at baseline and 6 months))
  • Change in Dietary Intake at 12 Weeks(12 weeks (at baseline and 12 weeks))
  • Change in Dietary Intake at 6 Months(6 months (at baseline, 12 weeks, 6 months))
  • Cost Analysis(6 months)

Study Sites (21)

Loading locations...

Similar Trials